ARMISTICE CAPITAL LLC 13D and 13G filings for Coeptis Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:59 pm Sale | 2024-09-30 | 13G | Coeptis Therapeutics, Inc. COEP | ARMISTICE CAPITAL LLC | 94,774 4.990% | -81,227 (-46.15%) | Filing |
| 2024-02-14 3:32 pm Purchase | 2023-12-31 | 13G | Coeptis Therapeutics, Inc. COEP | ARMISTICE CAPITAL LLC | 176,000 9.960% | 176,000 (New Position) | Filing |